Ostrolenk Faber Loses Bid To Reclaim Fees From Biotech Co.
A New York federal judge Wednesday dismissed Ostrolenk Faber LLP's breach of contract claim in a suit chasing $400,000 in allegedly unpaid fees from biotech company Unigene Laboratories Inc. for patent...To view the full article, register now.
Already a subscriber? Click here to view full article